Arxis, Inc. (NASDAQ:ARXS - Get Free Report) has earned an average rating of "Moderate Buy" from the eight brokerages that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $45.6667.
Several research firms have recently commented on ARXS. Royal Bank Of Canada began coverage on shares of Arxis in a research report on Monday. They set a "sector perform" rating and a $39.00 price target on the stock. Wolfe Research began coverage on shares of Arxis in a research report on Monday. They set an "outperform" rating and a $43.00 price target on the stock. Rothschild & Co Redburn set a $40.00 price target on shares of Arxis in a research report on Monday. UBS Group set a $53.00 price target on shares of Arxis in a research report on Monday. Finally, Robert W. Baird set a $55.00 price target on shares of Arxis and gave the company an "outperform" rating in a research report on Monday.
Read Our Latest Stock Report on ARXS
Insider Transactions at Arxis
In related news, insider Ross Bradley Sealfon bought 12,500 shares of the company's stock in a transaction that occurred on Friday, April 17th. The stock was purchased at an average price of $28.00 per share, for a total transaction of $350,000.00. Following the acquisition, the insider owned 1,102,807 shares of the company's stock, valued at approximately $30,878,596. This trade represents a 1.15% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Jason Aaron Roth bought 60,000 shares of the company's stock in a transaction that occurred on Friday, April 17th. The stock was bought at an average price of $28.00 per share, with a total value of $1,680,000.00. Following the acquisition, the insider directly owned 395,515 shares in the company, valued at $11,074,420. The trade was a 17.88% increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired 201,564 shares of company stock worth $5,643,792 in the last three months.
Arxis Stock Performance
ARXS stock opened at $35.10 on Monday. Arxis has a one year low of $34.44 and a one year high of $39.45.
About Arxis
(
Get Free Report)
We are a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components engineered for cutting-edge performance in extreme environments. Leveraging significant intellectual property (“IP”) and world-class engineering capabilities, we design and deliver innovative solutions that address some of our customers' most complex performance needs. Arxis is the result of a deliberate and disciplined strategy executed by our sponsor, Arcline, and the Arxis management team to create a purpose-built, cohesive business through targeted acquisitions with similar product and end market characteristics.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arxis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arxis wasn't on the list.
While Arxis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.